Concepedia

Tiemo J. Bandel

TJ

Statistics

Publications

10

Citations

4K

H-Index

10

Active since

1998

Affiliations

Bayer (Germany)(Current)

McMaster University

Sahlgrenska University Hospital

Aarhus University Hospital

Thrombosis Research Institute

Tiemo J. Bandel is an author at Bayer (Germany) specializing in medicine, cancer epidemiology, and urologic cancer epidemiology.

Top concepts

Publications per year

1998–2009

10

Publications

10

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Bengt I. Eriksson, Lars C. Borris, Richard J. Friedman et al. · New England Journal of Medicine · 2008 · 1.4K citations · Full text

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

Michael R. Lassen, Walter Ageno, Lars C. Borris et al. · New England Journal of Medicine · 2008 · 1.3K citations · Full text

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Alexander GG Turpie, Michael R. Lassen, Bruce L. Davidson et al. · The Lancet · 2009 · 978 citations

, , +8

Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement

Bengt I. Eriksson, A. K. Kakkar, Alexander G.G. Turpie et al. · Journal of Bone and Joint Surgery - British Volume · 2009 · 181 citations

Urothelial Cancer of the Bladder in an Area of Former Coal, Iron, and Steel Industries in Germany: A Case—Control Study

Klaus Golka, Tiemo J. Bandel, S Schlaefke et al. · International Journal of Occupational and Environmental Health · 1998 · 32 citations

, , +16

1–5 of 10